A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Pfizer
Pfizer
BioNTech SE
AstraZeneca
DualityBio Inc.
Hansoh BioMedical R&D Company
Eli Lilly and Company
Pfizer
DualityBio Inc.
Kura Oncology, Inc.
Jiangsu HengRui Medicine Co., Ltd.
Dallas VA Medical Center